Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy (OPIUM)

Regional University Hospital Center (CHRU)

Status: Active, not recruiting

Conditions: Myeloproliferative Neoplasm; Inflammatory Disease

Study type: Observational

Funder types: Other

Identifiers

NCT06476535

29BRC24.0155 - OPIUM

Details and patient eligibility

About

The study will collect cases of MPN patients who also benefit from an anti-inflammatory immunotherapy for another disease. Efficacy and tolerability of the drug will be assessed in this population.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• MyeloProliferative Neoplasm diagnosis
• receiving or having received an immunotherapy targeting IL-1, IL-6, IL-17, IL-23 or TNF

Exclusion criteria

• Unable to consent